U.S. Banks Stock News

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

California Water Service Group (CWT) is back on watch after recent share price moves, with the stock showing mixed returns over the past year as investors reassess this regulated water utility. See our latest analysis for California Water Service Group. At a share price of $45.01, California Water Service Group has recently seen a 7 day share price return of 2.51% but the 1 year total shareholder return is a decline of 4.2%. This suggests that recent momentum contrasts with weaker longer term...

If you are wondering whether Solaris Energy Infrastructure at US$57.83 is still attractively priced after its run, this section is designed to help you frame that question clearly. The stock has seen a 6.4% decline over the past week, a 4.7% gain over the last 30 days, a 15.1% gain year to date, and a 156.2% gain over the last year, which may signal shifting views on both its potential and its risks. Recent attention on the company has focused on its role in energy infrastructure and how...

Earlier this month, OpenText released a global report with the Ponemon Institute on managing risks and optimizing the value of AI, generative AI, and agentic AI, highlighting that many enterprises have adopted these tools without fully developed security and governance frameworks. The study’s finding that only a small minority of enterprises fully embed AI into cybersecurity and risk assessment underlines a widening gap between AI deployment and risk management that could influence how...

Markel Group (NYSE:MKL) has appointed Phil Jones as Chief Information Officer, International. Jones brings technology and operational experience across insurance, financial services, and government sectors. The role covers Markel International’s digital capabilities, operational resilience, and service delivery. For investors watching NYSE:MKL, this move highlights the growing importance of technology leadership for insurance and specialty risk businesses. As underwriting, claims, and...

Oklahoma Gas and Electric Company, a subsidiary of OGE Energy (NYSE:OGE), announced a new fixed-income offering of callable senior and subordinated unsecured fixed rate notes. The notes are structured as unsecured obligations and include both senior and subordinated tranches, with fixed interest rates. The securities are callable, meaning the issuer may choose to redeem them before maturity, subject to the offering terms. OGE Energy, through Oklahoma Gas and Electric, operates as a...

Some investors may be considering whether Grindr's current share price reflects its potential value, or whether the market is mispricing the stock at present. Over the past month, Grindr's share price has moved by 11.3%, while the 1 year return shows a 29.8% decline. This may draw the attention of investors who are weighing recent momentum against longer term performance. Recent coverage around Grindr has focused on its position as a listed interactive media and services platform, including...

BridgeBio Pharma has announced that long-term efficacy and safety results from the open-label extension of its Phase 3 ATTRibute-CM trial of acoramidis in ATTR-CM, including multiple analyses on survival, disease stabilization, and patient-reported outcomes, were presented at the American College of Cardiology Annual Scientific Sessions in New Orleans on March 28–30, 2026. The new data, alongside real-world survey findings on treatment patterns and preferences in ATTR-CM, offer a deeper view...

If you are wondering whether Global-E Online is starting to look attractive or still carries too much risk, its recent share price moves and current valuation metrics give you plenty to think about. The stock last closed at US$28.93, with returns of a 10.5% decline over 7 days, a 17.6% decline over 30 days, a 23.6% decline year to date and an 18.9% decline over 1 year. These moves may have shifted how the market is pricing its prospects and risks. These moves have come as Global-E Online...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

In March 2026, Alteogen announced an exclusive license deal giving Biogen rights to develop subcutaneous formulations for two biologic products using ALT-B4 Hybrozyme technology, while new data from Eisai and Biogen showed strong long-term real-world treatment persistence for intravenous lecanemab in Alzheimer’s patients. Together, these developments highlight Biogen’s push to expand patient-friendly biologic delivery and deepen its presence in Alzheimer’s care through therapies patients are...

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...

In its most recent quarter, First American Financial posted an exceptional performance with revenue rising 21.6% year on year, beating analyst forecasts by 15.2% and signaling strong recent business momentum. This combination of solid top-line growth and outperformance versus expectations highlights how the company’s operations have recently been executing ahead of what the market had modeled. We’ll now examine how this stronger-than-expected quarterly revenue performance might influence...

If you are wondering whether eToro Group at around US$29.05 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The share price closed at US$29.05, with a 1.3% decline over the past week, a 10.5% decline over the past month, and an 18.6% decline year to date, which may signal shifting views on both risk and potential. Recent coverage has focused on eToro Group as a publicly listed trading platform provider that gives investors access to a wide...

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...

Wondering if PTC Therapeutics at around US$66.13 is giving you a fair deal or asking too much for its future potential? This article breaks down what the current price might be implying. The stock has seen a mixed run recently, with a 1.3% gain over the last 7 days, a 2.4% decline over 30 days, a 13.8% decline year to date, a 21.9% return over 1 year, and 36.5% and 34.4% over 3 and 5 years respectively. Recent attention on PTC Therapeutics has centered on how investors are reassessing the...

Wondering if Generac Holdings at around US$194 per share still offers value, or if the easy gains are already behind it? This article focuses squarely on what the current price implies. The stock has had a mixed run, with a 2.5% decline over the last week and a 17.8% decline over the last month, while still sitting on returns of 37.8% year to date and 53.0% over the past year. Recent coverage of Generac has highlighted renewed interest in companies linked to backup power and grid resilience...

For readers wondering whether Brunswick's share price still offers value after a strong run, or if most of the potential upside is already reflected, this article focuses on what the numbers indicate about its valuation. Brunswick closed at US$70.95, with a 0.7% return over the last 7 days, a 12.4% decline over 30 days, a 6.5% decline year to date, and a 36.2% gain over 1 year. Over 3 years and 5 years the returns were declines of 7.3% and 19.0% respectively. Recent price moves are set...

On March 13, 2026, Liquidia’s Chief Medical Officer Rajeev Saggar sold 35,365 shares of common stock for about US$1.28 million, trimming roughly one sixth of his direct holdings. This sizeable insider sale comes while Liquidia’s core business appears to be progressing, highlighted by YUTREPIA’s reach to more than 2,900 patients and two straight profitable quarters. We’ll now examine how this sizeable insider sale amid ongoing YUTREPIA momentum may influence Liquidia’s broader investment...

Earlier in March 2026, Navitas Semiconductor announced a new GaNFast-based DC-DC power delivery board that directly converts 800 V to 6 V in a single stage, aiming to simplify power architectures and improve efficiency for advanced NVIDIA AI data center infrastructure. By removing the traditional 48 V intermediate bus and fitting high-power conversion into a profile thinner than a mobile phone, the design highlights how GaN technology can reclaim board space and support denser, more...

What recent price moves suggest about Sify Technologies (SIFY) Sify Technologies (SIFY) has seen sharp swings recently, with a 3.1% decline over the past day, a 7.1% drop across the past week, and a 20.4% slide over the past month. See our latest analysis for Sify Technologies. The recent slide in Sify Technologies' share price contrasts with its very large 1 year total shareholder return of 193.85%. At the same time, the 5 year total shareholder return of a 40.28% loss underlines how quickly...

Stryker (SYK) is back in focus after a cyberattack disrupted its manufacturing and electronic ordering systems, with the company now reporting restored access across most sites and renewed progress on production and fulfillment. See our latest analysis for Stryker. The recent cyberattack headlines come after a weaker patch for the stock, with a 30 day share price return of a 14.7% decline and a 1 year total shareholder return of a 9.3% loss, pointing to fading momentum despite positive multi...

Earlier this week, Progress Software announced that its ShareFile document collaboration platform now supports eIDAS-compliant Advanced and Qualified Electronic Signatures for UK and EU customers, integrating identity verification via Qualified Trust Service Providers into a single, auditable workflow. This move positions ShareFile as an all-in-one workspace for regulated industries, consolidating collaboration, high-assurance signing, and secure storage without relying on separate...

Earlier this week, Gates Industrial Corporation, a manufacturer of engineered power transmission and fluid power solutions, was lifted by easing geopolitical tensions as postponed military action against Iran reduced perceived risk for globally exposed industrial companies. This shift in geopolitical risk sentiment matters for Gates because its end markets, including construction equipment and manufacturing, are closely tied to global economic stability and confidence in longer-term capital...